Key earnings releases. Moderna, Siemens, Square, Zoetis, Deutsche Post, Merck KGaA, Adidas, Nintendo, Glencore, Bayer, Crédit Agricole, KBC, Swisscom , Zalando...

 

  • Valneva obtains positive results for the pivotal phase III study with its single injection chikungunya vaccine candidate.
  • Adidas: the group has raised its sales and profitability outlook for the year as a whole, despite a downturn in China, where Western brands faced a call for a boycott of their products at the end of March.
  • Atlantia: the Italian dealer returned to profit in the first half.
  • Bayer: 2021 guidance raised despite weak Q2 results.
  • Booking: the stock gained 3% after the close of Wall Street, after the publication of strong quarterly results.
  • Deutsche Lufthansa: the company reports slightly lower than expected losses and its first positive cash flow since the crisis.
  • Evonik: 2021 guidance raised.
  • MetLife: Q2 results beat expectations, allowing the stock to rise by 1.6% after the session.
  • Siemens: 2021 growth targets raised slightly.
  • Uber: the stock loses more than 4% after the release of mixed quarterly results.
  • WPP: 2021 targets raised.
  • Zurich Insurance takes over Deutsche Bank 's financial advisor network in Italy.
  • Rolls-Royce enters into exclusive discussions with Bain Capital on the sale of ITP Aero for a valuation that could reach $1.9bn, according to the latest rumors.
  • Bayer is buying Vividion Therapeutics for $2 billion.
  • Robinhood shares soared 50% yesterday.
  • General Motors lost 8% after disappointing results.
  • Novavax soars 21% after receiving an EU order for its Covid vaccine.
  • Temenos wins a contract with Australian bank Alex.
  • Weber's IPO price is lower than expected.